A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and ...

Ohio State University researchers develop RNA micelles, offering targeted chemotherapy for metastatic colorectal cancer.

Wave claimed GSK is handing back rights to the frontrunning program not because of questions about its potential, but because ...

QIMR Berghofer scientists have discovered a cancer-fighting RNA molecule that could hold the key to a new way of treating the ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers report a new RNA drug called TY1 improves heart healing in animals by repairing DNA and calming immune cells after ...

After GSK’s return of Wave Life Sciences’ WVE-006 as well as the mid-stage failure of Korro Bio’s candidate, the alpha-1 ...

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

An RNA medicine developed by Regeneron Pharmaceuticals and Alnylam Pharmaceuticals helped control symptoms of the chronic autoimmune disease generalized myasthenia gravis in adults enrolled in a ...

Roche is continuing its return to the RNA space by paying $200 million for the worldwide license to one of SanegeneBio’s ...

(a) Success rate, timeline, and cost (in billions) of traditional drug development versus RNA drug development, along with a description of the evolutionary progress of the latter. (b) The future ...

Leading RNA drug developer Suzhou Ribo Life Science Co. Ltd. passed its hearing for a listing on the Hong Kong Stock Exchange, marking the official launch of its IPO, according to its post-hearing ...